Michael A Garff

Title: Michael A. Garff: Innovator in Medical Diagnostics

Introduction

Michael A. Garff is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of malignant lung tumors. His innovative approach combines advanced technology with medical expertise to improve patient outcomes.

Latest Patents

Michael A. Garff holds a patent for a method titled "Method for diagnosing a malignant lung tumor." This method involves determining the presence of a disease condition in a medical patient by evaluating conductivity information. The process utilizes point-attribute values obtained from highly accurate conductivity data-sets taken over a period of time. These values are compared to previously determined threshold values to assess the patient's condition. Z-scores may be calculated to combine multiple point-attribute values into a composite score, which aids in diagnosing the disease. Additionally, z-scores can be weighted by the overall accuracy of the point-attribute in predicting the presence of the disease.

Career Highlights

Michael A. Garff is currently associated with Prolung, Inc., where he continues to develop innovative solutions in the medical field. His work focuses on enhancing diagnostic methods that can lead to earlier detection and better treatment options for patients suffering from lung tumors.

Collaborations

One of his notable collaborators is Steven C. Eror, with whom he has worked closely to advance their shared goals in medical diagnostics.

Conclusion

Michael A. Garff's contributions to medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work not only showcases his expertise but also highlights the importance of innovation in the medical field.